Abstract:To the editor: A 20-year-old Chinese female patient presented with several gradually enlarging, slightly pruritic plaques and nodules on her body over 3 years. Initially the patient had been diagnosed as dermatitis, cutaneous tuberculosis, and granuloma successively in local hospitals, while irresponsive to oral antihistamines, antitubercular agents, or topical corticosteroids. The patient had no fever, weight loss, or any remarkable past medical history. On physical examination, no lymphadenopathy was found. Several sporadic reddish plaques and nodules on the neck and shoulders, behind the ears were observed (Figure 1A). The largest lesion was on the right shoulder about 6 cm × 7 cm in size. They were a little swelling with poor activity. Laboratory examination revealed haematological tests, C-reactive protein, C3, C4, and antinuclear antibody levels were all within normal limits. Histological examination of the largest lesion revealed a diffuse infiltration by histiocytes, plasma cells, neutrophils, lymphocytes, and multinucleated giant cells in the dermis, and some histiocytes displayed emperipolesis (inflammatory cells within the cytoplasm of the histiocytes, with peripheral halos). The principal histiocytes were positive for S100 and CD68, of those sparse positive for CD1a (Figure 1 B-E), periodic acid-schiff staining (PAS, -), and acid-fast bacilli staining (-). Based on the clinicopathological findings, cutaneous Rosai-Dorfman disease (CRDD) accompanied by Langerhans cell hyperplasia was diagnosed. The progressive lesions over 3 years, the ineffectiveness of previous treatment, and the patient's complain of cosmetic appearance might represent a therapeutical challenge. We performed combined treatment, including oral prednisone (30 mg/d initially), thalidomide (75 mg/d), and intralesional injection of corticosteroid. The combined approaches started to work after 3 weeks, but the two larger nodules were irresponsive, prompting local electron beam irradiation therapy (30 Gy, 14 fractions). Following 2 weeks' treatment, it turned out to be effective, then prednisone tapered over the ensuing weeks. After 6 weeks of treatment, all the lesions were markedly improved (Figure 1F).Figure 1.: Clinical and histopathological manifestations of the patient. A: Skin manifestations on admission; B: Histopathological findings by haematoxylineosin (HE) staining: emperipolesis in consistence with Rosai-Dorfman cells (original magnification ×200); C: Immunohistological findings: Some histiocytes showed S-100 (+) (original magnification ×200); D: Immunohistological findings: Some histiocytes showed CD68 (+) (original magnification ×200); E:. Immunohistological findings: CD1a sparse (+) among those histiocytes (original magnification ×200); F: Skin lesions relieved markedly after therapy.CRDD, as an extranodal Rosai-Dorfman disease, is generally a benign idiopathic histiocytic disorder with distinctive clinicopathological appearance.1 Histopathologically the entity is characterized by emperipolesis of histiocytes with immunohistochemical staining positive for S100 and CD68 while negative for CD1a.2 In the current case, sparse CD1a (+) histiocytes presented in CRDD were unusual. Considering the diversified morphology of histiocytes, we postulated the movements of histiocytes in an active stage, which contains two possibilities, one might be a kind of reactivity, while the alternative might mean a forewarning for further progression. Distinct movements of histiocytes might lead to different prognosis.3 The etiology of RDD remains uncertain, despite documented associations with disorders of immune regulation4 (possibly following infection or an immune challenge, including herpesvirus 6 and Klebsiella spp.). A recent study defined CRDD as a histiocytic-mesenchymal transition by molecular, immunophenotypic, and sequencing analyses,5 which has thrown a new light on the investigation of its pathogenesis. Combined treatment might be helpful in patients with such entities.

Reactive Granulomatous Dermatitis: A Descriptive Study of 10 Patients

Underlying Systemic Diseases in Interstitial Granulomatous Dermatitis and Palisaded Neutrophilic Granulomatous Dermatitis: A Systematic Review

Granulomatous Disease in CVID: Retrospective Analysis of Clinical Characteristics and Treatment Efficacy in a Cohort of 59 Patients

Histopathological study of six types of adverse cutaneous drug reactions using granulysin expression

Clinicopathological Profile of Pyoderma Gangrenosum: A 10-Year Retrospective Study from a Tertiary Care Center in South India

P102 Cutaneous noninfectious manifestations of chronic granulomatous disease: a prospective study

Granulomatous Dermatitis and Others

Pyoderma Gangrenosum Associated With Iatrogenic Interleukin 17A Blockade: A Report of Two Cases and a Review of the Literature

Granular C3 dermatosis-A report of two cases and a mini-review of literature

Cutaneous Rosai-Dorfman Disease Accompanied by Langerhans Cell Hyperplasia Responsive to Combined Treatment

Deciphering Three Predominant Biopsy-Proven Phenotypes of IgG4-associated Kidney Disease: a Retrospective Study

P023 A case of ANCA-associated vasculitis with possible IgG4-related disease

[Clinical features and lymphocyte subtypes in patients with IgG4-related diseases]

Drug-Induced Pyoderma Gangrenosum: A Review

Clinical, epidemiological, and therapeutic hallmarks of pyoderma gangrenosum: a case series of 35 patients

Toxic epidermal necrolysis, DRESS, AGEP: Do overlap cases exist?

Drug-induced linear immunoglobulin A bullous dermatosis: A French retrospective pharmacovigilance study of 69 cases

Gamma-delta T-cell large granular lymphocytic leukemia in the setting of rheumatologic diseases

Patient Characteristics Associated With Reactions to Mrgprx2-Activating Drugs in an Electronic Health Record-Linked Biobank

Unusual Cases of Monoclonal Gammopathy of Renal Significance

FRI0622 A Retrospective Cohort Study about the Clinical Characteristics of Igg4-Related Diseases